|
1
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wells A, Grahovac J, Wheeler S, Ma B and
Lauffenburger D: Targeting tumor cell motility as a strategy
against invasion and metastasis. Trends Pharmacol Sci. 34:283–289.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Savagner P, Yamada KM and Thiery JP: The
zinc-finger protein slug causes desmosome dissociation, an initial
and necessary step for growth factor-induced epithelial-mesenchymal
transition. J Cell Biol. 137:1403–1419. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eger A, Aigner K, Sonderegger S, Dampier
B, Oehler S, Schreiber M, Berx G, Cano A, Beug H and Foisner R:
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates
epithelial plasticity in breast cancer cells. Oncogene.
24:2375–2385. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Buchwalter G, Gross C and Wasylyk B: Ets
ternary complex transcription factors. Gene. 324:1–14. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heo SH, Lee JY, Yang KM and Park KS: ELK3
expression correlates with cell migration, invasion, and membrane
type 1-matrix metalloproteinase expression in MDA-MB-231 breast
cancer cells. Gene Expr. 16:197–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee JH, Hur W, Hong SW, Kim JH, Kim SM,
Lee EB and Yoon SK: ELK3 promotes the migration and invasion of
liver cancer stem cells by targeting HIF-1α. Oncol Rep. 37:813–822.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kong SY, Kim KS, Kim J, Kim MK, Lee KH,
Lee JY, Oh N, Park JI, Park JH, Heo SH, et al: The ELK3-GATA3 axis
orchestrates invasion and metastasis of breast cancer cells in
vitro and in vivo. Oncotarget. 7:65137–65146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim KS, Kim J, Oh N, Kim MY and Park KS:
ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating
cell-cell adhesion-related genes. Biochem Biophys Res Commun.
498:509–515. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao
WH, Liu XY, Wang Y, Yang ZC, Xu HM and Wang HB: Transforming growth
factor-beta 1 enhances the invasiveness of breast cancer cells by
inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Oncol Rep. 29:219–225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cho HJ, Oh N, Park JH, Kim KS, Kim HK, Lee
E, Hwang S, Kim SJ and Park KS: ZEB1 collaborates with ELK3 to
repress E-cadherin expression in triple negative breast cancer
cells. Mol Cancer Res. 17:2257–2266. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang YY, Brunicardi FC and Lin X: Smad3
mediates immediate early induction of Id1 by TGF-beta. Cell Res.
19:140–148. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kavsak P, Rasmussen RK, Causing CG, Bonni
S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an
E3 ubiquitin ligase that targets the TGF beta receptor for
degradation. Mol Cell. 6:1365–1375. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bu P, Wang L, Chen KY, Rakhilin N, Sun J,
Closa A, Tung KL, King S, Kristine Varanko A, Xu Y, et al: miR-1269
promotes metastasis and forms a positive feedback loop with TGF-β.
Nat Commun. 6:68792015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park SY, Kim MJ, Park SA, Kim JS, Min KN,
Kim DK, Lim W, Nam JS and Sheen YY: Combinatorial TGF-β attenuation
with paclitaxel inhibits the epithelial-to-mesenchymal transition
and breast cancer stem-like cells. Oncotarget. 6:37526–37543. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Semenchenko K, Wasylyk C, Cheung H,
Tourrette Y, Maas P, Schalken JA, van der Pluijm G and Wasylyk B:
XRP44X, an inhibitor of Ras/Erk activation of the transcription
factor Elk3, inhibits tumour growth and metastasis in mice. PLoS
One. 11:e01595312016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pickup M, Novitskiy S and Moses HL: The
roles of TGFβ in the tumour microenvironment. Nat Rev Cancer.
13:788–799. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dalal BI, Keown PA and Greenberg AH:
Immunocytochemical localization of secreted transforming growth
factor-beta 1 to the advancing edges of primary tumors and to lymph
node metastases of human mammary carcinoma. Am J Pathol.
143:381–389. 1993.PubMed/NCBI
|
|
23
|
Steiner MS, Zhou ZZ, Tonb DC and Barrack
ER: Expression of transforming growth factor-beta 1 in prostate
cancer. Endocrinology. 135:2240–2247. 1994. View Article : Google Scholar : PubMed/NCBI
|
